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= Objective: To determine the effect of continu- 
ous acupressure at P, applied by Sea-Bands with 
acupressure buttons on the frequency and severity 
of nausea and vomiting of pregnancy during the 
1 st trimester. 
Design: A two-group, quasi-experimental, 
posttest-only and posttest-repeated measure. 
Setting: Seventeen medical clinics or offices 
in southern Michigan. 
Participants: Convenience sample of English- 
speaking, healthy pregnant women in their 1 st tri- 
mester, who had at least one episode of nausea, 
vomiting, or both before their prenatal clinic/office 
visit where they were recruited. After being accept- 
ed for the study, the women were randomly assigned 
to treatment or placebo groups. 
Intervention: Treatment group 1 applied Sea- 
Bands with acupressure buttons to both wrists for 4 
days and removed the Sea-Bands for 3 subsequent 
days. Placebo group 2 applied the Sea-Bands with- 
out acupressure buttons to both wrists on the same 
time schedule as group 1. 
Main Outcome Measure: Self-report daily 
diaries of the number of times per day that partici- 
pants experienced nausea, the severity of nausea, 
the number of vomiting episodes per day, and the 
severity of vomiting. 
Results: Mann-Whitney U procedures revealed 
that the treatment group had significantly less fre- 
quency and severity of nausea and vomiting of 
pregnancy while wearing the Sea-Bands than did 
the placebo group. The treatment group also had 
significantly less frequency and severity of nausea 
and vomiting of pregnancy while wearing the Sea- 
Bands than when not wearing the Sea-Bands. 
Conclusions: Sea-Bands with acupressure 
buttons are a noninvasive, inexpensive, safe, and 
effective treatment for the nausea and vomiting of 
pregnancy. JOGNN, 30,61-70; 2001 . 
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Nausea with or without vomiting during preg- 
nancy is experienced by 50-70% of pregnant 
women and is a universal phenomenon that occurs 
most frequently between weeks 5 and 12 of ges- 
tation (Murphy, 1998; O’Brien & Zhou, 1995; 
Pillitteri, 1995). Although the condition is usually 
self-limited by the end of the 1st trimester, the 
symptomatic period may lead to nutritional 
deficits, dehydration, weakness, weight loss, and 
electrolyte imbalance (Murphy, 1998; Stainton & 
Neff, 1994). Nearly one third of women with 
nausea and/or vomiting of pregnancy (NVP) report 
considerable distress and disruption in family, 
emotional, or social functioning (O’Brien & 
Naber, 1992). In affected women who are em- 
ployed, nearly 50% believe that their efficiency at 
work is reduced, and 25% require time off (Vel- 
lacott, Cooke, & James, 1988). 
The etiology of NVP is not clearly understood. 
Findings from epidemiologic studies that evaluat- 
ed relationships between NVP and a variety of 
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physiologic, psychologic, psychosocial, and demograph- 
ic variables have been equivocal and even contradictory. 
Some investigators have reported a positive association 
between symptoms and maternal factors (personality 
factors, age, parity, education level, weight, smoking 
habits) and fetal factors (gender, birth weight), whereas 
others failed to support these associations (Depue, Bern- 
stein, Ross, Judd, & Henderson, 1987; Hsu & Witter, 
1993; Janfelt-Samsioe, Samsioe, & Velinder, 1983; Kle- 
banoff, Koslowe, Kaslow, & Rhodes, 1985; O’Brien, 
1991; O’Brien & Zhou, 1995; Tierson, Olsen, & Hook, 
1986). 
Because there is no definitive maternal or fetal cause, 
few effective treatment options are available to women 
experiencing NVP. Since the 1940s, vitamin B, (pyri- 
doxine) has been included in the formulation of drugs 
for the prevention of NVP (Weinstein, Wohl, Mitchell, & 
Susendal, 1944; Willis, Winn, Morris, Newsom, & 
Massey, 1942). Many health care providers continue to re- 
%ere is  a great need for a safe, effective, 
and side-effect-free intervention for the 
nausea and vomiting of pregnancy. 
commend vitamin B, for control of NVP, yet studies 
provide only minimal support for the relationship be- 
tween vitamin B, and prevalence or degree of NVP 
(Sahakian, Rouse, Sipes, Rose, & Niebyl, 1991; Vutya- 
vanich, Wongtrangan, & Ruangsri, 1995). Before 1983, 
a medication containing a combination of vitamin B, 
and doxylamine succinate provided an effective antiemet- 
ic; however, evidence that the vitamin B, component 
contributed to its effectiveness was never supported 
(Dilorio, 1988). The medication was withdrawn from 
the market in 1983 after several lawsuits alleging birth 
defects related to its use (Omstein, Einarson, & Koren, 
1995). 
Although some pharmacologic antiemetics are avail- 
able, many pregnant women are reluctant to take them 
for fear of possible teratogenic effects on the fetus dur- 
ing this critical embryogenic period (Murphy, 1998). 
The Food and Drug Administration lists most such 
medications as Category C. This category indicates that 
there is minimal information about the drugs concern- 
ing safety or risk in humans. 
Acupressure is considered one of the nonpharmaco- 
logic and noninvasive treatment modalities for NVP. 
Others are alterations of eating and drinking patterns, 
vitamins, herbals, and homeopathic preparations (Mur- 
phy, 1998). Few women report complete relief from 
these modalities, and their potential risks and adverse 
effects are unknown (O’Brien & Naber, 1992). Clearly, 
with no dependable nonpharmacologic treatment avail- 
able, there is a great need for an intervention that is 
safe, effective, and free of side effects. In recent years, 
acupressure has been looked on as a treatment modali- 
ty possibly meeting these criteria. It is a noninvasive, 
inexpensive, and safe treatment that may be a success- 
ful self-help option for pregnant women experiencing 
NVP. All of these modalities need to be studied more 
thoroughly. 
Theoretical Framework 
There is no known physiologic basis for acupressure. 
According to Beal(1992a, 1992b), acupressure is based 
on ancient Chinese traditions reflecting the philoso- 
phies of Taoism and Confucianism. These philosophies 
describe health as a state of relative balance within the 
person and in the context of his or her environmental 
surroundings. The basic life force of ch’i empowers 
human life. Ch’i flows through the body in meridians 
(pathways) that are accessible to acupressure and acu- 
puncture treatments that change the flow imbalances. 
According to Chinese medicine, acupressure for NVP 
involves bilateral wrist pressure that rebalances energy 
so that the negative energy in the body is first redirect- 
ed away from the heart using the right P, point, where- 
as more positive energy comes into the body through 
the left P, point. This process restores the balance of the 
life forces and controls nausea (Stainton & Neff, 1994). 
Acupressure for NVP involves constant pressure of the 
pericardial median at the Neiguan (P,) point, located 
three finger breadths from the wrist crease on the volar 
surface of the arm between the palmaris longus and 
flexor carpi radialis. 
Many meridian-oriented treatment approaches for 
acupressure require a high level of knowledge and ex- 
perience to apply properly (Beal, 1992a). One simple 
alternative acupressure intervention that requires mini- 
mal knowledge and experience is the Sea-Band wrist- 
band (Sea-Band, U.K., Ltd., Leicester, England). Sea- 
Bands are l-inch-wide elasticized cloth wristbands with 
a convex plastic button that is worn against the skin. 
They are packaged with insert instructions illustrating 
exactly where to place them on the wrists to exert even 
pressure on the P, point (see Figure 1). 
Literature Review 
The dearth of research supporting or refuting the 
efficacy of all remedies has left a therapeutic gap in the 
treatment of NVP. This problem, along with the current 
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SEA-BAND PLACEMENT - 
FIGURE 1 
Placement of Sea-Bands with acupressure button at the P, 
point located three fingers below the wrist crease. 
and increasing interest in complementary medicine, led 
researchers to investigate the use of acupressure. Six 
clinical trials studying the efficacy of acupressure at the 
Neiguan point (P,) as an antiemetic for NVP were iden- 
tified through a literature review. Only one study 
reported no effectiveness (O’Brien, Relyea, & Taerum, 
1996), whereas the other five demonstrated some sup- 
port for the antiemetic action of P, acupressure (Bay- 
reuther, Lewith, & Pickering, 1994; Belluomini, Litt, 
Lee, & Katz, 1994; De Aloysio & Penacchioni, 1992; 
Dundee, Sourial, Ghaly, & Bell, 1988; Hyde, 1989). 
One of the most recent studies (O’Brien et al., 1996) 
demonstrated no apparent medical benefit from the use 
of P, acupressure. This study used Sea-Bands on both 
wrists and performed experimental and placebo tests 
on 161 pregnant women in their 1st trimester. All par- 
ticipants were assigned to one of three groups (i.e., P, 
acupressure, placebo acupressure bands inappropriate- 
ly placed, or control) on the basis of a process of 
blocked randomization. One hundred forty-nine preg- 
nant women completed the protocol. Irrespective of 
group assignment, the women reported decreases in 
nausea and vomiting or retching. Thus, there was no 
differential treatment effect in reducing or relieving the 
symptoms of nausea with or without vomiting and 
retching during pregnancy as a result of acupressure. 
Three of the studies found that during the 1st 
trimester, acupressure at the P, point may reduce nau- 
sea but not vomiting (Bayreuther et al., 1994; Belluo- 
mini et al., 1994; Hyde, 1989). In the other two studies 
that demonstrated support, the collection methods did 
not permit separate analysis for nausea and vomiting 
(DeAloysio & Penacchioni, 1992; Dundee et al., 1988). 
In Dundee et al.3 (1988) study, the treatment group 
reported 8.5% reduction in nausea and vomiting. 
However, the gestational age was significantly greater 
in this group. Because the study did not use a crossover 
design, it is unknown if gestational age in itself may 
have accounted for the lower reporting of nausea and 
vomiting (Dundee et al., 1988). Also, there was no 
description in Dundee’s report of how acupressure was 
applied or any explanation for the significantly lower 
rates of return in the treatment group. Hyde (1989) 
used a crossover design, and 12 of the 16 participants 
reported a reduction in nausea and vomiting in preg- 
nancy. In Hyde’s study, the sample was small and there 
was no control group for study of a placebo effect. The 
sample in the study by Bayreuther et al. (1994) also was 
small, with a high dropout rate. Although the studies of 
Hyde and Bayreuther support the use of acupressure, 
one must be cautious when the sample is so small. 
Review of the literature reveals an incomplete under- 
standing of NVP, lack of effective treatment modalities, 
and inconclusive support for the use of acupressure. 
This leaves nurses without an effective intervention 
based on sound research. Clearly, the review of the lit- 
erature confirms the need for nurses to study the effi- 
cacy of acupressure, which is cost-effective, free of side 
effects, and noninvasive. It has gained rather rapid 
N u r s e s  need to study the efficacy of 
acupressure, which has gained rapid 
acceptance, a I thoug h with on I y I i m i ted 
scientific investigation. 
acceptance with only limited scientific investigatian. 
For nurses to confidently offer Sea-Bands as a remedy 
for NVP, the effectiveness of the intervention requires 
further evaluation. The purpose of this investigation 
was to determine if continuous acupressure at  P, 
applied by Sea-Bands decreased the frequency and 
severity of nausea and vomiting in pregnancy during 
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the 1st trimester. The current study tested the following 
hypotheses: 
1. The frequency and severity of nausea will be less 
among pregnant women wearing acupressure Sea- 
Bands than among women wearing placebo Sea-Bands. 
2. The frequency and severity of vomiting will be less 
among pregnant women wearing acupressure Sea- 
Bands than among women wearing placebo Sea-Bands. 
3 .  The frequency and severity of nausea will be less when 
pregnant women are wearing acupressure Sea-Bands 
than when they are not wearing the bands. 
4. The frequency and severity of vomiting will be less 
when pregnant women are wearing acupressure Sea- 
Bands than when they are not wearing the bands. 
Design and Method 
A two-group, quasi-experimental, posttest-only and 
posttest-repeated measure design (Campbell & Stanley, 
1963) was used to address the research question, Does 
continuous acupressure at P, applied by Sea-Bands 
decrease the frequency and severity of nausea and vom- 
iting of pregnancy during the 1st trimester? To address 
this question, a convenience sample of pregnant women 
in their 1st trimester was recruited on a voluntary basis 
in 17 obstetric/gynecology offices and clinics in south- 
ern Michigan. Criteria for participation were (a) self- 
report of one or more episodes of pregnancy-related 
nausea and/or vomiting, (b) less than 13 weeks preg- 
nant, and (c) able to read and speak English. The design 
also provided for the participants to serve as their own 
control (when they removed the Sea-Bands) for the last 
3 days of the study period. 
After the university subject review board approved 
the study design and instruments, participants were 
recruited through nurses at the participating offices and 
clinics. All women who met the inclusion criteria were 
asked to participate. Assignment of participants to 
group 1 (treatment, Sea-Band with acupressure button) 
or group 2 (placebo, Sea-Band without acupressure 
button) occurred after the pregnant women agreed to 
participate in the study and signed the consent form. 
Each office or clinic was given a box containing an 
equal number of treatment and placebo packets. To 
prevent identification as to whether treatment or place- 
bo, the unlabeled sealed packets were shuffled before 
delivery to the offices. 
An explanation of the study, a cover sheet, a consent 
form, and a demographic questionnaire were stapled to 
the outside of the sealed packet. Inside the sealed pack- 
et were written instructions, seven daily logs, and Sea- 
Bands with or without acupressure buttons. Written 
instructions to the participants included the following: 
1. Place one wristband on each wrist three finger breadths 
from the wrist crease. (If the wristband had an acu- 
pressure button, the nurse also instructed the partici- 
pant to place the button as illustrated and directed on 
the Sea-Band package.) 
2. Wear the wristbands continuously for 4 days. (The 
removal date and time [96 hours later] were written on 
the instruction sheet for participants.) 
3. Write responses on the dated daily log each evening just 
before going to bed. 
4. Continue writing responses on the daily logs for 3 
evenings after removing the wristbands. 
5. Mail the seven completed logs to the investigators in a 
preaddressed, postage-paid envelope. 
Investigators conducted training sessions with the 
nurses from each clinic or office that agreed to assist in 
the study. Each nurse was given a script for instructing 
participants and explicit information and demonstra- 
tion in the placement of the Sea-Bands. After the train- 
ing session, all nurses were required to give a return 
proficiency demonstration in the study methods. 
All trained nurses in the clinics or offices read a writ- 
ten explanation of the study to potential participants. 
When a pregnant woman agreed to take part in the 
study, the nurse randomly selected a sealed packet from 
the study box. Before opening the sealed packet, the 
participant signed a consent form and completed a 
demographic questionnaire and a cover sheet. The 
nurse then opened the sealed packet and removed the 
contents. The participants were not informed of which 
type of Sea-Band they had been given. Both groups 1 
and 2 received detailed written and oral instructions for 
the logs and Sea-Bands. The participants from both 
groups applied a Sea-Band on each of their wrists with 
the assistance of the nurses. The nurses made certain 
that participants used their own fingers to measure 
three finger breadths from the creases in their wrists. 
Group 1 participants also were instructed to place the 
pressure button between flexor tendons of the medial 
aspect of both forearms. These instructions were con- 
sistent with those provided by the Sea-Band distributor. 
This day was considered the 1st of the 7 days of the 
study for the participant. 
Both groups were instructed to wear the wristbands 
continuously (remove only when bathing), while con- 
currently maintaining the daily log for 4 days. At the end 
of the 96th hour, both groups were instructed to remove 
the wristbands but to continue to maintain the daily 
diaries for an additional 72 hours. The control period 
was limited to 72 hours to reduce nonadherence in symp- 
tomatic women who might be tempted to put the wrist- 
bands back on if they had relief while wearing the Sea- 
Bands. On completion of the 72nd hour, they mailed 
the daily logs back to the investigators. When the inves- 
tigators received a placebo-coded log, the participant 
was telephoned and offered a free pair of Sea-Bands 
with a pressure button. This gesture was provided be- 
cause the investigators felt that each participant, whether 
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in the treatment or placebo group, should have an op- 
portunity to use the Sea-Bands with acupressure buttons. 
Instruments 
A self-report demographic questionnaire was used to 
obtain background information. The questionnaire was 
designed specifically for this study to include contex- 
tual factors, which according to the literature reviewed, 
could affect the results. The factors included were age, 
gestational age, race, education, marital status, gravi- 
da, first NVP episode, nausea proneness, vitamin use, 
importance of significant other, and type of medical 
insurance. A cover sheet was used to collect identifying 
information for each participant. It was used only for 
sending follow-up reminder postcards if logs were not 
received and for sending those in the placebo group free 
Sea-Bands after the study was completed. 
Each participant recorded her perception of the fre- 
quency and severity of nausea and vomiting for 7 days 
in a daily log. The daily log was a modified and abbre- 
viated version of the Rhodes Index of Nausea and 
Vomiting (Rhodes, Watson, & Johnson, 1984), which 
had been adapted by Brown, North, Marvel, and Fons 
(1992) for their study of acupressure wristbands to 
relieve nausea and vomiting in hospice patients. The 
Rhodes Index of Nausea and Vomiting has been used 
extensively in research and has an established validity 
with populations of pregnant women (O’Brien, 1991; 
Stainton & Neff, 1994). The instrument has an esti- 
mated reliability of at least 0.83 and a correlation of .37 
between its construct and concurrent validity (Rhodes 
et al., 1984). The version of the instrument used in the 
current study was that used in the Brown et al. (1992) 
study, with two changes. In the Brown et al. version, 
the third question asked participants how long they 
were nauseated. The version used in this study asked 
women how many times they were nauseated. In this 
study, a fifth question about the wearing of bands also 
was added. 
Therefore, the four closed-ended questions used to 
measure participants’ perception of their frequency and 
severity of nausea and vomiting were (a) How many 
times today did you feel nauseated or queasy? (b) How 
bad was your nausea or queasiness today? (c) How 
many times did your throw up (vomit) or have dry 
heaves today? and (d) How bad was your vomiting/dry 
heaves today? Responses were recorded on a 5-point 
Likert-type scale for frequency (0 = none, 1 = one to 
two times, 2 = three to four times, 3 = five to six times, 
and 4 = seven or more times) and for severity (0 = none, 
1 = mild, 2 = moderate, 3 = severe, and 4 = horrible). A 
fifth question was used to measure the participants’ 
perception of whether the Sea-Bands helped to reduce 
NVP: 1 = did not help, 2 = helped a little, 3 = helped a 
lot, 4 = did not wear bands today, This fifth question 
also assisted the investigators in confirming whether 
the participants actually had taken the Sea-Bands off 
for the last 3 days of the 7-day study. 
Because vitamin B, and prenatal vitamins are rou- 
tinely recommended by the participating clinics and 
offices, the logs also included questions as to whether 
the women took either of these supplements. An addi- 
tional six questions about the number of large or small 
meals consumed and the amount and type of fluid 
intake also were included in the daily logs. 
Results 
One hundred thirty-eight pregnant women in 17 dif- 
ferent prenatal clinics or offices in southern Michigan 
accepted the invitation to participate in this study. Of 
these, 110 participants completed the data collection 
and mailed their results to the investigators. The 
remaining 28 were not included because of insufficient 
data provided. Of the 28, 17 were in the treatment 
group and 11 were in the placebo group. No other 
information was available on the women who agreed to 
participate but did not complete the study. 
Sixty-eight of the completed logs were from women 
in group 1 (treatment, Sea-Bands with acupressure but- 
tons) and 42 were from women in group 2 (placebo, Sea- 
Bands with no acupressure buttons). Mann-Whitney U, 
chi-square, and Fisher’s exact tests revealed that the 
groups were not significantly different in background 
characteristics (see Table 1). 
This research was guided by the following question: 
Does continuous acupressure at P,, applied by Sea- 
Bands, decrease the frequency and severity of NVP dur- 
ing the 1st trimester? The first two hypotheses were 
tested to address the question. Mann-Whitney U proce- 
dures were used to determine if there were measurable 
differences between group 1 and group 2 in the fre- 
quency and severity of NVP during the 4-day treatment 
period. All four research hypotheses were supported 
(see Table 2). 
The nonparametric procedure, Wilcoxin’s matched 
pairs, signed-rank test, was used to test for the differ- 
ences between Days 1-4 and Days 5-7, when the wo- 
men served as their own experimental controls. The last 
two research hypotheses were supported (see Table 3) .  
Although no hypotheses were identified comparing 
the groups’ results for Days 5-7, the results are includ- 
ed here for further discussion. The medians for all four 
measures were higher for Days 5-7 than for Days 1-4. 
Differences in the frequency and severity of nausea and 
vomiting were less between group 1 and group 2 during 
Days 5-7 than during the treatment period Days 1-4. 
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TABLE 1 
Sample Description: Background Variables of Participants (N = 110) 
' Variable n 
Nausea frequency 
Group 1 68 
Group 2 42 
Group 1 68 
Group 2 42 
Group 1 68 
Group 2 42 
Group 1 68 








































The tests for probability for Days 5-7, however, 
showed significant differences between treatment and 
placebo groups only in frequency of nausea and severi- 
ty of vomiting but not in severity of nausea or frequen- 
cy of vomiting (see Table 4).  
Table 5 shows the results of the Wilcoxin's matched 
pairs, signed-rank tests for group 2. This group showed 
significantly less frequency and severity of vomiting dur- 
ing the time they wore the placebo Sea-Bands (Days 1- 
4) than after they removed them (Days 5-7). There were 
no differences in either frequency or severity of nausea. 
Because many of the women in both group 1 (40%) 
and group 2 (37%) were taking vitamin B,during the 7 
study days, further investigation into the possibility of 
a treatment effect of vitamin B, seemed warranted. To 
separate any effects exerted on NVP by vitamin B, , the 
two groups were divided again. Group 1 was divided into 
nontakers and takers of vitamin B,, as was group 2. 
Medians for frequency and severity of NVP were cal- 
culated for each of the four groups and tested for dif- 
ferences with the Mann-Whitney U. Within the treat- 
ment group, during treatment Days 1-4, the takers of 
vitamin B, had significantly less frequency and severity 
of N V P  than did the nontakers of vitamin B,. Within 
the placebo group, during Days 1-4, the takers also 
showed significantly less frequency and severity of NVP 
than did the nontakers (see Tables 6 and 7). There were 
T h e  pregnant women who wore Sea-Bands 
with acupressure buttons had less frequency 
and severiiy of nausea and vomiting of 
pregnancy than did the women who wore 
Sea-Bands without acupressure buttons. 
TABLE 2 
Mann- Wbitney U Comparison of Independent 
Gvoups: Group 1 and Group 2 During Days 
1-4 (wearing Sea-Bands) 







39.28 434.0* * 
73.65 
no significant differences between the takers and the 
nontakers of vitamin B, within either group 1 or group 2 
during Days 5-7. These were days neither group 1 nor 
group 2 wore the Sea-Bands (see Tables 8 and 9). 
Discussion 
The 68 pregnant women who wore Sea-Bands with 
acupressure buttons (treatment group) had significant- 
ly less frequency and severity of NVP while wearing the 
Sea-Bands than did the 42 pregnant women who wore 
Sea-Bands without acupressure buttons (placebo 
group). Thus, the first two research hypotheses were 
accepted. 
The treatment group also had significantly less fre- 
quency and severity of NVP while wearing the Sea- 
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TABLE 3 
Results of Wilcoxin's Matched Pairs, Signed-Rank Test Within Grozrp 1: Differences Betweepi Exper- 
imental Period Days 1-4 and Control Period Days 5-7 
~ 
Nausea Vomiting 
Test Statistic Frequency Severity Frequency Severity 
Z -5.285** -5.394** -4.736* * -5.287'' 
' 'p c .0005, one-tailed. 
TABLE 4 
Maniz- Whitney U Cornparisoiz of lndepen- 
dent Groups ( 1  = treatment; 2 = placebo) Dur- 
ing Days 5-7 (not wearing Sea-Bands) 









Average severity of nausea 
Average frequency of vomiting 
Average severity of vomiting 
'p c .05, one-tailed. 
Mean 













Bands with the acupressure button (Days 1-4) than 
they did after removal (Days 5-7). Thus, the last two 
hypotheses were accepted. 
The treatment group had significantly less frequency 
of nausea and less severity of vomiting during Days 5-7 
than did the placebo group. Although the medians for 
all four measures were less for the treatment group than 
the placebo group, there was no statistical difference in 
severity of nausea or frequency of vomiting between the 
groups. This could be a residual effect of the Sea-Bands 
for 24 hours after the bands are removed. To investi- 
gate this, Mann-Whitney U tests were used on Days 6 
and 7, eliminating Day 5. Nearly identical results were 
found, ruling out any residual effect of Sea-Band treat- 
ment in this study. 
The placebo group, when using themselves as con- 
trols (Days 5-7), showed significantly less frequency 
and severity of vomiting during Days 1-4 when they 
wore the placebo Sea-Bands than they did after remov- 
ing the Sea-Bands. However, there were no significant 
differences in either frequency or severity of nausea with- 
in this group between the time they wore the placebo 
Sea-Bands and when they did not. This may reflect a lack 
of clarity in reporting because one would expect a feel- 
ing of nausea to precede actual vomiting. Thus, all four 
tests indicated that acupressure through Sea-Bands is 
an effective remedy for NVP. 
The test for the influence of vitamin B, further con- 
firmed the effect of the Sea-Bands. The takers of vita- 
min B, in the treatment group had significantly less fre- 
quency and severity of NVP during the first 4 days than 
did the nontakers. Whereas Sea-Band treatment had 
lowered NVP overall, this finding suggests that there 
may be a positive, synergistic effect of the dual treat- 
ment. During Days 5-7, after Sea-Band removal, there 
were no significant differences between the takers and 
nontakers of vitamin B, among participants in the treat- 
ment group. 
The effect of vitamin B, was similar in both the treat- 
ment and placebo groups. Vitamin B, was effective 
while participants wore Sea-Bands but not effective when 
they did not wear them. In this case, one has to ques- 
tion if a placebo effect occurred with the group wearing 
Sea-Bands without acupressure buttons. Is it possible to 
have a synergistic effect with a placebo Sea-Band? 
When both groups removed the Sea-Bands, the vitamin 
B, made no difference. Therefore, vitamin B, , by itself, 
cannot be considered to be an effective treatment. 
Limitations 
A limitation associated with this study was the use of 
ordinal rather than interval data, which reduced the 
power of the findings. Thus, the recommendation for 
further research is to use actual numbers rather than 
ranges. A power analysis based on Cohen's (1992) for- 
mula determined that the sample size necessary to 
achieve an anticipated medium effect size with a power 
of 0.80 and an alpha of .05 was 170 (85 in each group). 
The final sample size in this study was 110, with 68 in 
group 1 and 42 in group 2. A limitation with regard to 
the sample size is that if a larger sample with 85 in 
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TABLE 5 
Results of Wilcoxin’s Matched Pairs, Signed-Rank Test Among Group 2 (placebo): Differences 
Between Experimental Period Days 1-4 and Control Peviod Days 5-7 
Nausea Vomiting 
Test Statistic Frequency Severiiy Frequency Severiiy 
Z -.820 -1.555 -1.849* -2.383“ 
“ p  c .OS, one-tailed. 
TABLE 6 
Mann- Whitney U Comparison of lndepen- 
dent Samples: Nontakers of Vitamin B, (n = 
35) and Takers of Vitamin B ,  (n = 29) Within 
Group 1 Pavticipants (treatment), Days 1-4 
Average frequency of nausea 
Nontakers of vitamin B, 
Takers of vitamin B, 
Average severity of nausea 
Nontakers of vitamin B, 
Takers of vitamin B, 
Nontakers of vitamin B, 
Takers of vitamin B, 
Nontakers of vitamin B, 
Takers of vitamin B, 
Average frequency of vomiting 
Average frequency of vomiting 














each group had been used, there would have been a 
reduced risk of possibly committing a Type I error. 
Another limitation was that the frequency and severity 
of NVP was not determined before participants 
enrolled in the study. They were required to have had 
at least one episode but were not asked to provide addi- 
tional data. A pretest would have provided one more 
comparison and strengthened the study. It would have 
been interesting to determine the effect of the Sea- 
Bands on subsets of participants who experienced mod- 
erate or greater nausea and vomiting versus those who 
had mild or less nausea and vomiting, but this was not 
done in this study. The validity of self-reporting is 
always in question. 
Implications for Nursing 
Today, more than ever, health care reform calls on 
nursing to provide cost-effective care. Nurses are respon- 
TABLE 7 
Mann-Whitney U Comparison of lndepen- 
dent Samples: Nontakers of Vitamin B,, (n = 
22) and Takers of Vitamin B ,  (n =19) Within 
Group 2 (placebo), Days 1-4 
Average frequency of nausea 
Nontakers of vitamin B, 
Takers of vitamin B, 
Average severity of nausea 
Nontakers of vitamin B, 
Takers of vitamin B, 
Nontakers of vitamin B, 
Takers of vitamin B, 
Average severity of vomiting 
Nontakers of vitamin B, 
Takers of vitamin B, 
Average frequency of vomiting 














sible for clinical judgments (nursing diagnoses) based 
on an individual’s responses to actual or potential health 
problems and life processes (Carpenito, 1997). These 
nursing diagnoses provide the basis for selection of 
appropriate interventions to achieve positive outcomes. 
When a pregnant woman is experiencing NVP, acu- 
pressure would afford nurses a cost-effective, safe, eas- 
ily implemented intervention that uses the body’s own 
mechanisms to restore homeostasis and requires no 
prescription. Acupressure not only may eliminate the 
physiologic discomforts associated with NVP but also 
assist in maintaining or increasing productivity as well 
as reducing disruption in family, emotional, and social 
functioning. With just one noninvasive intervention, 
the nurse could achieve many positive outcomes for the 
pregnant woman experiencing NVP. Further research 
on other nonpharmacologic modalities is indicated. 
Nursing has a responsibility to know the effects of non- 
pharmacologic interventions. 
68 JOG” Volume 30, Number 1 
TABLE a 
Mann- Wbitney U Comparison of Zndepen- 
dent Samples: Nontakers of Vitamin B, (n = 
36) and Takers of Vitamin B, (n = 27) Within 




Rank U taikd) 
Average frequency of nausea 432.5 ns 
Nontakers of vitamin B, 30.51 
Takers of vitamin B, 33.98 
Nontakers of vitamin B, 31.00 
Takers of vitamin B, 33.33 
Nontakers of vitamin B, 29.69 
Takers of vitamin B, 35.07 
Nontakers of vitamin B6 30.58 
Takers of vitamin B, 33.89 
Average severity of nausea 450.0 ns 
Average frequency of vomiting 403.0 ns 
Average severity of vomiting 435.0 ns 
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